Minimally invasive assessment of peripheral residual disease (PRD) during maintenance or observation in patients (Pts) with multiple myeloma (MM): An update from the GEM2017FIT clinical trial
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Carmen Gonzalez, Marta Lasa, Cristina Agullo, Natalia Buenache, Laura Notarfranchi, Anastasiia Zherniakova, Maria Calasanz, Sergio Castro, Jose Perez, Veronica Gonzalez-Calle, Maria Teresa Cedena Romero, Alejandro Martín-Muñoz, Santiago Barrio Garcia, Albert Oriol, Enrique Ocio, Anna Sureda Balarí, Yolanda González-Montes, Angel Ramirez, Laura Rosiñol Dachs, Ana Lopez-Guia, Joan Bargay, Sunil Lakhwani, Luis Felipe Casado Montero, Joan Batista Blade Creixenti, Juan-Jose Lahuerta Palacios, Jesus San-Miguel, María-Victoria Mateos, Joaquin Martinez-Lopez, Noemi Puig, Bruno Paiva
Institutions: Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Hospital Universitario 12 De Octubre, University of Parma, Russian Research Institute of Hematology and Transfusiology, Institut Català d'Oncologia, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, Institut d'Investigació Biomédica de Bellvitge, Duran i Reynals Hospital, Universitat de Barcelona, Hospital Universitari de Girona Doctor Josep Trueta, Hospital Universitario Central de Asturias, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario La Paz, Hospital Son Llatzer, Health Research Institute of the Balearic Islands, Hospital Universitario de Canarias, Complejo Hospitalario Universitario de Toledo
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010291
Cites:
Cited by:
Related to: